2013 Press Releases


  • For Altitude Training, a Narrow Window for Success

    Released December 12, 2013 - In a new study, researchers found that living between 2000 and 2500 meters above sea level offered the best performance enhancement compared to living at higher or lower elevations. These findings could help competitive endurance athletes and their coaches develop altitude training regimens that have the highest chance of success.
  • Transmitting Future Asthma by Smoking Today

    Released September 20, 2013 - A new study confirms the lasting legacy of smoking. In the study, researchers exposed animal mothers to nicotine during pregnancy—a proxy for smoking—and found the grandchildren were also at an increased risk for asthma, despite the grandchildren never having been exposed to nicotine themselves.
  • Cutting Back on Sleep Harms Blood Vessel Function and Breathing Control

    Released April 22, 2013 - Researchers have tested the effects of partial sleep deprivation on blood vessels and breathing control and found that reducing sleep length over two consecutive nights leads to less healthy vascular function and impaired breathing control. The findings could help explain why sleep deprivation is associated with cardiovascular disease.
  • Two Days of Staging as Effective as Four for High Altitude Climbs

    Released April 21, 2013 - Conventional knowledge suggests that to avoid acute mountain sickness (AMS), climbers need to “stage,” or set up camp, at a lower altitude for four days when summiting peaks as high as 4300 meters. A U.S. Army Research Institute of Environmental Medicine team has found that two days of staging at a moderate altitude may be enough.
  • Household Air Pollution (HAP) and Biomass Fuels

    Released April 1, 2013 - Almost 4 million people die annually from household air pollution (HAP) caused by exposure to the combustion of biomass fuels, kerosene, or coal. These individuals are among the tens of millions who rely on the products for cooking, heating, and light. A new article explains the need for improved HAP biomarkers, and more.